drugset / Trial / NCT02421601
A Study of SI-6603 in Patients With Lumbar Disc Herniation
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of SI-6603(Condoliase) in patients with lumbar disc herniation.
Timeline
- Start
- 2015-03
- Primary completion
- 2018-02
- Completion
- 2018-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Condoliase | Protein / enzyme biologic | 1.25 unknown | Other |